Karine Khatchadourian

Investigator, CHEO Research Institute

Dr Khatchadourian completed medical school and a pediatrics residency at the University of Montreal. She then completed her fellowship in pediatric endocrinology at BC Children’s Hospital at the University of British Columbia. She also obtained a Master’s in health sciences at the University of British Columbia.
Dr Karine Khatchadourian is a pediatric endocrinologist at the Children’s Hospital of Eastern Ontario and an Assistant Professor of Pediatrics at the University of Ottawa. She has been providing hormone therapy and support to transgender adolescents since 2014 at CHEO. She is the medical co-director of CHEO’s Diversity Program.
She published the first Canadian study (and second North American) characterizing the endocrine management of transgender adolescents. She has supervised three pediatric endocrine fellows in research projects examining effects of GnRH agonist therapy in transgender adolescents. She was also a site co-Investigator for the Trans Youth CAN! Study. She is a co-investigator for a new CIHR funded study looking at identifying and examining health outcomes and healthcare utilization among transgender adolescents and youth accessing gender-affirming care in Ontario.

She has collaborated on different bone health and diabetes studies within the Endocrinology division at CHEO. She also has an interest in general endocrinology research. She is the principal investigator of an RCT comparing the effect and safety of once weekly dosing of somapacitan with daily Norditopin® as well as evaluating long-term safety of somapacitan in children with Turner syndrome.

Research Projects

  1. Control-IQ Technology Positively Impacts Patient Reported Outcome Measures and Glycemic Control in Youth with Type 1 Diabetes in a Real-World Setting


    Initiation of Control-IQ technology in a real-world setting significantly reduced the impact of diabetes on daily life while simultaneously improving glycemic control